1. General
  2. Others

  3. Others

Dr. Reddy launches Sildenafil tablets

India Infoline News Service | Mumbai | November 19, 2012 09:51 IST

The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.

Dr. Reddy's Laboratories announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets.


The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.


Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes.

BSE 3,150.50 [9.95] ([0.31]%)
NSE 3,151.25 [9.10] ([0.29]%)

***Note: This is a BSE Chart









article
113110705590
Dr. Reddy launches Sildenafil tablets
Dr. Reddy launches Sildenafil tablets
The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.
http://www.indiainfoline.com/article/news-top-story/dr-reddy-launches-sildenafil-tablets-113110705590_1.html
November 19, 2012 09:51 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Dr. Reddy,Sildenafil tablets
Others
$rawVideoFileUrl$
$videoPlayerUrl$
 

 
 
Reports
News